UBS reiterates its 'sell' recommendation on the stock and lowers its target price to €3.5 (from €4.25).

UBS says that Worldline's Q1 results were in line with expectations, but the lack of strategic guidance is causing concern. A restructuring plan is underway, which points to potential difficulties in the short term.

The group announced that it would not update its outlook for 2025 before the publication of its H1 results, scheduled for 30 July.


Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are provided solely as a decision-making aid for investors. Cercle Finance cannot be held liable, directly or indirectly, for the use of such information and analyses by readers. Anyone who is not an expert in the field is advised to consult a professional advisor before investing. This information is provided for informational purposes only and does not constitute an offer to sell or a solicitation to buy.